JAMES C BLAIR
CIK 1024000 · last filed 2021-06-11
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$529.62M
Companies
24
Total Filings
127
Lifetime Open-Market Net
$73.71M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Clovis Oncology, Inc. (CLVS) Delisted | Director | 53,439 | $0.08 | $4.3K | -$62.21M | 22 | 2021-06-11 |
| LIFE | Director | 1,807,820 | $15.61 | $28.22M | $0 | 7 | 2019-05-10 |
| Dicerna Pharmaceuticals Inc (DRNA) Delisted | 10%+ Owner | 3,482,033 | $38.22 | $133.08M | $0 | 3 | 2017-12-20 |
| CoLucid Pharmaceuticals, Inc. (CLCD) Delisted | 10%+ Owner | 3,168 | — | — | -$10.4K | 2 | 2016-08-03 |
| Evoke Pharma Inc (OMED) Delisted | 10%+ Owner | 35,296 | — | — | -$1.71M | 5 | 2016-04-21 |
| SNDX | 10%+ Owner | 1,743,854 | $18.25 | $31.83M | $0 | 1 | 2016-03-08 |
| GKOS | 10%+ Owner | 2,077,660 | $126.81 | $263.47M | $0 | 1 | 2015-07-01 |
| ESPR | 10%+ Owner | 2,597,397 | $3.15 | $8.18M | $74.00M | 2 | 2014-10-21 |
| Achaogen, Inc. (AKAO) Delisted | 10%+ Owner | 1,987,049 | — | — | $0 | 1 | 2014-03-17 |
| TNDM | 10%+ Owner | 3,189,058 | $16.60 | $52.94M | $0 | 1 | 2013-11-19 |
| VCYT | 10%+ Owner | 3,063,294 | $47.33 | $144.99M | $0 | 1 | 2013-11-04 |
| Tobira Therapeutics, Inc. (RGDO) Delisted | 10%+ Owner | 4,614 | — | — | $3.00M | 1 | 2013-08-28 |
| Ocera Therapeutics, Inc. (TZYM) Delisted | 10%+ Owner | 47,963 | — | — | $8.00M | 1 | 2013-07-16 |
| ALIMERA SCIENCES INC (ALIM) Delisted | 10%+ Owner | 3,938,997 | $5.54 | $21.82M | -$1.71M | 5 | 2013-06-20 |
| ZOGENIX, INC. (ZGNX) Delisted | Director | 9,923,335 | $26.68 | $264.75M | $16.40M | 6 | 2013-06-19 |
| CADENCE PHARMACEUTICALS INC (CADX) Delisted | Director | 2,417,824 | — | — | $8.10M | 24 | 2013-06-13 |
| ACHILLION PHARMACEUTICALS INC (ACHN) Delisted | 10%+ Owner | 5,772,968 | — | — | $0 | 3 | 2013-01-18 |
| Durata Therapeutics, Inc. (DRTX) Delisted | 10%+ Owner | 2,227,596 | — | — | $7.06M | 1 | 2012-07-24 |
| Orexigen Therapeutics, Inc. (OREX) Delisted | 10%+ Owner | 70,016 | — | — | $24.29M | 14 | 2011-12-22 |
| Paratek Pharmaceuticals, Inc. (NOVC) Delisted | Director | 67,875 | — | — | -$514.6K | 4 | 2009-01-30 |
| Volcano Corp (VOLC) Delisted | Director | 1,939,456 | — | — | -$985.0K | 10 | 2008-07-18 |
| PHARMION CORP (PHRM) Delisted | Director | — | — | — | $0 | 1 | 2007-06-08 |
| NUVASIVE INC (NUVA) Delisted | Director | 3,457 | $39.75 | $137.4K | $0 | 3 | 2007-05-29 |
| SENORX INC (SENO) Delisted | 10%+ Owner | 24,665 | — | — | $0 | 1 | 2007-04-03 |
Recent Filings · Page 11 of 13
127 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2009-02-20 | CADENCE PHARMACEUTICALS INC (CADX) Delisted | Buy (P) | +2,780,674 | $19.83M | EDGAR |
| 2009-01-30 | Paratek Pharmaceuticals, Inc. (NOVC) Delisted | Sell (S) | −250,000 | -$238.8K | EDGAR |
| 2008-12-10 | Orexigen Therapeutics, Inc. (OREX) Delisted | Buy (P) | +490,301 | $2.30M | EDGAR |
| 2008-07-18 | Volcano Corp (VOLC) Delisted | Mixed | −1,150,000 | -$280.5K | EDGAR |
| 2008-06-19 | CADENCE PHARMACEUTICALS INC (CADX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2008-06-09 | Volcano Corp (VOLC) Delisted | Other (J) | +31,061 | $0 | EDGAR |
| 2008-04-10 | Volcano Corp (VOLC) Delisted | Mixed | −1,000,000 | -$218.5K | EDGAR |
| 2008-03-19 | — | Mixed | −2,336,135 | $0 | |
| 2008-02-22 | CADENCE PHARMACEUTICALS INC (CADX) Delisted | Grant (A) | +2,808,988 | $15.00M | EDGAR |
| 2007-11-29 | Orexigen Therapeutics, Inc. (OREX) Delisted | Mixed | −899,664 | -$299.7K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.